KQB162

N/A

Report date: 2025/11/06 17:16:13
NME

Base Information

Drug NameKQB162
Drug Alias NameKQB-162
ClassificationSmall molecules
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulators
TargetsGTPase KRas
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKumquat Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesKumquat Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A